Comparison of Treatment of Severe High-Density Lipoprotein Cholesterol Deficiency in Men With Daily Atorvastatin (20 mg) Versus Fenofibrate (200 mg) Versus Extended-Release Niacin (2 g)

Khalid Alrasadi, Zuhier Awan, Khalid Alwaili, Isabelle Ruel, Anouar Hafiane, Larbi Krimbou, Jacques Genest

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

To determine whether available lipid-modifying medication can increase high-density lipoprotein (HDL) cholesterol in well-defined genetic or familial HDL-deficiency states, we studied 19 men with HDL deficiency (HDL cholesterol

Original languageEnglish
Pages (from-to)1341-1347
Number of pages7
JournalAmerican Journal of Cardiology
Volume102
Issue number10
DOIs
Publication statusPublished - Nov 15 2008

Fingerprint

Fenofibrate
Niacin
HDL Cholesterol
Lipids
Therapeutics
Atorvastatin Calcium
Familial HDL deficiency

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Comparison of Treatment of Severe High-Density Lipoprotein Cholesterol Deficiency in Men With Daily Atorvastatin (20 mg) Versus Fenofibrate (200 mg) Versus Extended-Release Niacin (2 g). / Alrasadi, Khalid; Awan, Zuhier; Alwaili, Khalid; Ruel, Isabelle; Hafiane, Anouar; Krimbou, Larbi; Genest, Jacques.

In: American Journal of Cardiology, Vol. 102, No. 10, 15.11.2008, p. 1341-1347.

Research output: Contribution to journalArticle

@article{dc074b4ec69c4ca9aeb9418dc4b512d2,
title = "Comparison of Treatment of Severe High-Density Lipoprotein Cholesterol Deficiency in Men With Daily Atorvastatin (20 mg) Versus Fenofibrate (200 mg) Versus Extended-Release Niacin (2 g)",
abstract = "To determine whether available lipid-modifying medication can increase high-density lipoprotein (HDL) cholesterol in well-defined genetic or familial HDL-deficiency states, we studied 19 men with HDL deficiency (HDL cholesterol",
author = "Khalid Alrasadi and Zuhier Awan and Khalid Alwaili and Isabelle Ruel and Anouar Hafiane and Larbi Krimbou and Jacques Genest",
year = "2008",
month = "11",
day = "15",
doi = "10.1016/j.amjcard.2008.07.010",
language = "English",
volume = "102",
pages = "1341--1347",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "10",

}

TY - JOUR

T1 - Comparison of Treatment of Severe High-Density Lipoprotein Cholesterol Deficiency in Men With Daily Atorvastatin (20 mg) Versus Fenofibrate (200 mg) Versus Extended-Release Niacin (2 g)

AU - Alrasadi, Khalid

AU - Awan, Zuhier

AU - Alwaili, Khalid

AU - Ruel, Isabelle

AU - Hafiane, Anouar

AU - Krimbou, Larbi

AU - Genest, Jacques

PY - 2008/11/15

Y1 - 2008/11/15

N2 - To determine whether available lipid-modifying medication can increase high-density lipoprotein (HDL) cholesterol in well-defined genetic or familial HDL-deficiency states, we studied 19 men with HDL deficiency (HDL cholesterol

AB - To determine whether available lipid-modifying medication can increase high-density lipoprotein (HDL) cholesterol in well-defined genetic or familial HDL-deficiency states, we studied 19 men with HDL deficiency (HDL cholesterol

UR - http://www.scopus.com/inward/record.url?scp=55249084748&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=55249084748&partnerID=8YFLogxK

U2 - 10.1016/j.amjcard.2008.07.010

DO - 10.1016/j.amjcard.2008.07.010

M3 - Article

VL - 102

SP - 1341

EP - 1347

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 10

ER -